Coca-Cola’s recent announcement that it will offer a cane sugar–sweetened version of its flagship beverage this fall in the U.S. has rekindled a long-standing debate about sweeteners. While the current formula relies on high-fructose corn syrup (HFCS), a resurgence of interest in cane sugar has prompted both consumers and experts to wonder: Is one truly healthier than the other? This article examines the science behind these sweeteners, presents the clinical evidence available to date, debunks common misconceptions, and offers practical guidance on sugar consumption—all while providing expert insights into this sweet showdown.
──────────────────────────────
Background & Context
For decades, sodas and sugar-sweetened beverages have sparked concerns among health professionals due to their links to obesity, Type 2 diabetes, heart disease, and other metabolic conditions. The debate over which sweetener is “better”—cane sugar or HFCS—has persisted despite chemical similarities. Cane sugar is almost exclusively sucrose (roughly 50% glucose and 50% fructose), making it essentially the same as table sugar. In contrast, the most common HFCS used in beverages comprises 55% fructose and 45% glucose. Although the difference in the percentages may seem minor, the varying proportions have raised questions about their metabolic impacts.
